Cornerstone Capital Management Holdings’s PDL BioPharma, Inc. PDLI Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$342K	Sell	125,096 -28,000	-18%	-$86K	﹤0.01%	1064
2017 Q3	$518K	Buy	153,096 +7,600	+5%	+$21.1K	﹤0.01%	1052
2017 Q2	$358K	Sell	145,496 -17,189	-11%	-$39.5K	﹤0.01%	1076
2017 Q1	$368K	Buy	+162,685	New	+$360K	﹤0.01%	1097
2016 Q4	–	Sell	-498,400	Closed	-$1.67M	–	1496
2016 Q3	$1.67M	Buy	498,400 +21,200	+4%	+$67.3K	0.01%	817
2016 Q2	$1.5M	Buy	+477,200	New	+$1.59M	0.01%	805
2014 Q4	–	Sell	-178,750	Closed	-$1.33M	–	1390
2014 Q3	$1.33M	Sell	178,750 -166,800	-48%	-$1.55M	0.01%	812
2014 Q2	$3.34M	Buy	345,550 +233,450	+208%	+$2.08M	0.04%	521
2014 Q1	$932K	Buy	112,100 +105,600	+1,625%	+$905K	0.01%	886
2013 Q4	$54K	Buy	+6,500	New	+$54.8K	﹤0.01%	1165

Other funds holding PDLI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Cornerstone Capital Management Holdings's PDLI Position: Q4 2017 in Review

Cornerstone Capital Management Holdings reduced its PDL BioPharma, Inc. (PDLI) stake by 18% in Q4 2017, selling an estimated $86K and leaving 125,096 shares worth $342K. The position accounts for ﹤0.01% of the portfolio, ranked #1064.

Cornerstone Capital Management Holdings first reported a position in PDLI in Q4 2013 and has held it in 10 quarters since. The position peaked at $3.34M in Q2 2014. 187 funds tracked by Wall St. Rank hold PDLI as of Q4 2017.

Cornerstone Capital Management Holdings held 125,096 shares of PDL BioPharma, Inc. worth $342K as of Q4 2017.
Cornerstone Capital Management Holdings sold 28,000 PDL BioPharma, Inc. shares in Q4 2017, an estimated $86K.
PDL BioPharma, Inc. made up ﹤0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #1064 holding.
Cornerstone Capital Management Holdings first reported a position in PDL BioPharma, Inc. in Q4 2013 and has held it in 10 quarters since.
Cornerstone Capital Management Holdings's PDL BioPharma, Inc. position peaked at $3.34M in Q2 2014.
187 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.